Nissha Co Ltd (Nissha) is an electronics manufacturer. Its products include MDs (in-mold decoration), heat transfer foils, 3D dye sublimation, lamination for glass and film products, capacitive-type, and resistive-type touch panels, sensing devices, commercial printing and publishing, medical-surgical devices, and medical electrodes for cardiovascular devices. Nissha's products and services are used in various industries including mobility, mobile devices, home appliances, medical technologies, food and consumer goods, cosmetics, and industrial equipment. It also offers contract design and manufacturing services for major medical device manufacturers and produces brands of products for medical institutions.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Nissha’s commitment to research and development (R&D) is a critical strength that drives innovation and supports its competitive positioning. Nissha’s growth is driven by six core technologies such as printing, coating, lamination, molding, patterning, and metal processing which enable it to develop distinctive product lines and expand into diverse global markets. Nissha’s R&D is structured across two levels: business unit development departments handle mid-term projects tailored to specific customer requests. The Business Development Office aims to expand the business domain of our group by researching and planning development themes and promoting the development and commercialization of new products, while also working to expand core technologies. This strategy is supported by global development bases that adapt to unique regional market environments. In FY2025, the company incurred an expense of JPY4,124 million on R&D, which as a percentage of revenue stood at 2.1%.